URAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) ) or thrombin. The
blood of male donor patients (n = 60) with acute de novo thrombosis (n = 90) was used. Using
popularity, including the use of
blood
components or
blood cells with a haemostatic purpose. In this re gard